1. Academic Validation
  2. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

  • Biochem J. 1999 Oct 1;343 Pt 1(Pt 1):209-14.
J M Leiper 1 J Santa Maria A Chubb R J MacAllister I G Charles G S Whitley P Vallance
Affiliations

Affiliation

  • 1 Centre for Clinical Pharmacology, The Rayne Institute, University College London, 5 University Street, London, U.K.
PMID: 10493931
Abstract

Methylarginines inhibit nitric oxide synthases (NOS). Cellular concentrations of methylarginines are determined in part by the activity of dimethylarginine dimethylaminohydrolase (DDAH; EC 3.5.3. 18). We have cloned human DDAH and identified and expressed a second novel DDAH isoform (DDAH I and II respectively). DDAH I predominates in tissues that express neuronal NOS. DDAH II predominates in tissues expressing endothelial NOS. These results strengthen the hypothesis that methylarginine concentration is actively regulated and identify molecular targets for the tissue and cell-specific regulation of methylarginine concentration.

Figures